Virtual Medicinal Product (VMP) - Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Darunavir 800mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir alafenamide 10mg tablets Start Date 02-04-2025 End Date
Previous Name Previous Name Generic Symtuza 800mg/150mg/200mg/10mg tablets Start Date 18-10-2017 End Date 01-04-2025
Abbreviated Name Abbreviated Name Darunavir 800mg/Cobicistat/Emtr/Tenofovir alafenamide tab Start Date 02-04-2025

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
Other

Codes

ATC Code
J05AR22
BNF Codes
  • BNF code 05030100
SNOMED Codes
Code Start Date End Date
34878311000001101 18-10-2017

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Cobicistat Based on Ingredient Substance 150 mg
Darunavir ethanolate Based on Base Substance Darunavir 800 mg
Emtricitabine Based on Ingredient Substance 200 mg
Tenofovir alafenamide fumarate Based on Base Substance Tenofovir alafenamide 10 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
30 tablet